CIAM
LUCD icon

Caitong International Asset Management’s Lucid Diagnostics LUCD Stock Holding History

Caitong International Asset Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Sell
1
-2
-67% -$2 ﹤0.01% 2889
2026
Q1 		$3 Buy
+3
New +$4 ﹤0.01% 2384

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Caitong International Asset Management's LUCD Position: Q2 2026 in Review

Caitong International Asset Management reduced its Lucid Diagnostics (LUCD) stake by 67% in Q2 2026, selling an estimated $2 and leaving 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Caitong International Asset Management first reported a position in LUCD in Q1 2026 and has held it in 2 quarters since. The position peaked at $3 in Q1 2026. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Caitong International Asset Management held 1 share of Lucid Diagnostics worth $1 as of Q2 2026.
  • Caitong International Asset Management sold 2 Lucid Diagnostics shares in Q2 2026, an estimated $2.
  • Lucid Diagnostics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2889 holding.
  • Caitong International Asset Management first reported a position in Lucid Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • Caitong International Asset Management's Lucid Diagnostics position peaked at $3 in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.